Postprandial variations in fibrinolytic activity in middle-aged men are modulated by plasminogen activator inhibitor I 4G-675/5G genotype but not by the fat content of a meal

American Journal of Clinical Nutrition

Volumn 79, Issue 4, 2004, Pages 577-581

  Sanders, Thomas A B ^a   De Grassi, Tamara ^a   Acharya, Jayshree ^c   Miller, George J ^b   Humphries, Steve E ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Fibrinolysis; Monounsaturated fatty acids; PAI 4G 675 5G; PAI 1; Plasminogen activator inhibitor 1; Saturated fatty acids

Indexed keywords

BLOOD CLOTTING FACTOR 7; FAT; OLEIC ACID; PALMITIC ACID; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL; CHOLESTEROL;

ADULT; AGE DISTRIBUTION; AGED; ALLELE; ARTICLE; BLOOD CLOT LYSIS; BLOOD CLOTTING; BLOOD CLOTTING TIME; BODY MASS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; DIETARY INTAKE; FAT CONTENT; FIBRINOLYSIS; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIPID DIET; LOW FAT DIET; MALE; MEASUREMENT; NORMAL HUMAN; PARALLEL DESIGN; POSTPRANDIAL STATE; RANDOMIZATION; STATISTICAL SIGNIFICANCE; TEST MEAL; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; DRUG EFFECT; FAT INTAKE; GENETICS; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ARIDA;

CHOLESTEROL; DIETARY FATS; FASTING; FIBRINOLYSIS; GENOTYPE; HUMANS; MALE; MIDDLE AGED; OLEIC ACID; PALMITIC ACID; PLASMINOGEN ACTIVATOR INHIBITOR 1; POSTPRANDIAL PERIOD;

EID: 2142657292     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/79.4.577     Document Type: Article

References (23)

1. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993;342:1076-9.
2. MacCallum PK, Cooper JA, Howarth DJ, Meade TW, Miller GJ. Sex differences in the determinants of fibrinolytic activity. Thromb Haemost 1998;79:587-90.
3. Asplund-Carlson A, Hamsten A, Wiman B, Carlson LA. Relationship between plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic men. Diabetologia 1993;36:817-25.
4. Simpson HC, Mann JI, Meade TW, Chakrabarti R, Stirling Y, Woolf L. Hypertriglyceridaemia and hypercoagulability. Lancet 1983;1:786-90.
5. Ye S, Green FR, Scarabin PY, et al. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de i'nfarctus du Mycocarde. Thromb Haemost 1995;74:837-41.
6. Panahloo A, Mohamed-Ali V, Lane A, Green F, Humphries SE, Yudkin JS. Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene. Diabetes 1995;44:37-42.
7. Fu L, Jin H, Song K, Zhang C, Shen J, Huang Y. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction. Chin Med J 2001;114:266-9.
8. Boekholdt SM, Bijsterveld NR, Moons AH, Levi M, Buller HR, Peters RJ. Genetic variation in coagulation and fibrinolytic proteins and their 3 relation with acute myocardial infarction: a systematic review. Circulation. 2001;104:3063-8.
9. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Miletich JP. Arterial and venous thrombosis is not associated with the 4G:5G polymorphism in the promoter of the plasminogen activator gene in a large cohort of US men. Circulation 1997;95:59-62.
10. Byrne CD, Wareham NJ, Martensz ND, Humphries SE, Metcalfe J, Grainger DJ. Increased PAI-1 activity and PAI-1 antigen occurring with an oral fat load: associations with PAI-1 genotype and plasma active TGF-β levels. Atherosclerosis 1998;140:45-53.
11. Sanders TA, de Grassi T, Miller GJ, Humphries SE. Dietary oleic and palmitic acids and postprandial factor VII in middle- aged men heterozygous and homozygous for factor VII R353Q polymorphism. Am J Clin Nutr 1999;69:220-5.
12. Menon IS, Martin A, Weightman D. Estimation of euglobulin lysis time using a time-saving recorder. Lab Practice 1969;18:1186-7.
13. Margaglione M, Grandone E, Cappucci G, et al. An alternative method for PAI-1 promoter polymorphism (4G/5G) typing. Thromb Haemost 1997;77:605-6.
14. Fearnley GR, Balmforth G, Fearnley E. Evidence of a diurnal fibrinolytic rhythm; with a simple method of measuring natural fibrinolysis. Clin Sci 1957;16:645-50.
15. Marckmann P, Sandstrom B, Jespersen J. Dietary effects on circadian fluctuation in human blood coagulation factor VII and fibrinolysis. Atherosclerosis 1993;101:225-34.
16. Oakley FR, Sanders TA, Miller GJ. Postprandial effects of an oleic acid rich oil compared with butter on clotting factor vii and fibrinolysis in healthy men. Am J Clin Nutr 1998;68:1202-7.
17. Sanders TA, Oakley FR, Cooper JA, Miller GJ. Influence of a stearic acid-rich structured triacylglycerol on postprandial lipemia, factor VII concentrations, and fibrinolytic activity in healthy subjects. Am J Clin Nutr 2001;73:715-21.
18. Kozima Y, Urano T, Serizawa K, Takada Y, Takada A. Impaired fibrinolytic activity induced by ingestion of butter: effect of increased plasma lipids on the fibrinolytic activity. Thromb Res 1993;70:191-202.
19. Rankinen T, Vaisanen S, Penttila I, Rauramaa R. Acute dynamic exercise increases fibrinolytic activity. Thromb Haemost 1995;73:281-6.
20. Hoekstra T, Geleijnse JM, Schouten EG, Kluft C. Diurnal variation in PAI-1 activity predominantly confined to the 4G-allele of the PAI-1 gene. Thromb Haemost 2002;88:794-8.
21. Van Der Bom JG, Bots ML, Haverkate F, Kluft C, Grobbee DE. The 4G5G polymorphism in the gene for PAI-1 and the circadian oscillation of plasma PAI-1. Blood 2003;101:1841-4.
22. Vaisanen SB, Humphries SE, Luong LA, Penttila I, Bouchard C, Rauramaa R. Regular exercise, plasminogen activator inhibitor-1 (PAI-1) activity and the 4G/5G promoter polymorphism in the PAI-1 gene. Thromb Haemost 1999;82:1117-20.
23. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001;29:306-9.